Laxmi Dental Ltd

Laxmi Dental Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Laxmi Dental Ltd

₹ 249 20.00%
22 May - close price
laxmidentallimited.com BSE: 544339 NSE: LAXMIDENTL
About

Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]

Key Points

Leading Dental Company[1]
Laxmi Dental is India’s only end-to-end integrated dental products company, operating across the full dental value chain — dental laboratory services, clear aligners, aligner materials & machines, and paediatric dental products. It is the second-largest domestic dental lab player and the largest Indian export dental laboratory

Website BSE NSE
  • Market Cap ₹ 1,370 Cr.
  • Current Price ₹ 249
  • High / Low ₹ 510 / 156
  • Stock P/E 59.2
  • Book Value ₹ 45.0
  • Dividend Yield 0.00 %
  • ROCE 12.3 %
  • ROE 9.86 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 59.9% CAGR over last 5 years
  • Debtor days have improved from 69.9 to 54.2 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Working capital days have increased from 115 days to 201 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
34.92 39.14 43.23 41.99 43.35 42.68 50.11 54.26 48.45 55.74
33.81 32.96 34.75 37.22 37.77 35.34 40.15 46.58 43.88 47.71
Operating Profit 1.11 6.18 8.48 4.77 5.58 7.34 9.96 7.68 4.57 8.03
OPM % 3.18% 15.79% 19.62% 11.36% 12.87% 17.20% 19.88% 14.15% 9.43% 14.41%
3.07 3.87 10.52 2.92 2.04 3.33 2.68 3.38 -2.12 1.99
Interest 1.10 1.19 1.08 0.86 1.01 0.70 0.14 0.14 0.23 0.27
Depreciation 2.49 2.34 2.19 2.13 2.67 2.83 2.48 2.64 3.06 3.33
Profit before tax 0.59 6.52 15.73 4.70 3.94 7.14 10.02 8.28 -0.84 6.42
Tax % -200.00% 8.74% 7.31% 19.15% 18.53% 41.74% 21.56% 20.77% 123.81% -5.92%
1.76 5.96 14.59 3.80 3.21 4.18 7.86 6.57 -1.89 6.80
EPS in Rs 57.16 193.57 5.25 1.37 0.62 0.76 1.43 1.20 -0.34 1.24
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
112 63 113 126 139 171 209
110 59 109 119 128 144 178
Operating Profit 3 4 4 6 12 27 30
OPM % 3% 7% 3% 5% 8% 16% 15%
1 0 4 8 14 19 6
Interest 3 3 3 4 5 4 1
Depreciation 6 6 7 9 9 10 12
Profit before tax -5 -4 -2 1 12 32 24
Tax % 5% 9% 118% 0% -85% 18% 19%
-5 -4 -4 1 23 26 19
EPS in Rs -155.57 -140.95 -142.58 46.12 737.58 4.69 3.52
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 27%
3 Years: 18%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: 60%
3 Years: 246%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -37%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 16%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.31 0.31 0.31 0.31 0.31 11 11
Reserves 44 40 36 28 51 212 236
36 36 41 42 53 5 11
28 29 29 37 31 48 31
Total Liabilities 109 105 106 108 136 276 289
38 41 32 35 33 40 54
CWIP 0 0 0 0 0 0 0
Investments 16 16 17 14 14 17 79
54 48 57 59 89 219 156
Total Assets 109 105 106 108 136 276 289

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
10 10 -4 10 5 47 -35
-15 -9 3 -6 -6 -49 -46
6 -1 1 -1 -2 104 -3
Net Cash Flow 0 1 -1 3 -3 102 -85
Free Cash Flow -7 1 -2 3 -2 34 -52
CFO/OP 340% 247% -84% 156% 45% 180% -97%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 90 95 73 85 88 68 54
Inventory Days 189 377 195 162 196 132 111
Days Payable 184 310 147 151 82 196 45
Cash Conversion Cycle 95 162 120 95 201 4 120
Working Capital Days 21 9 27 20 71 72 201
ROCE % 0% 1% 6% 19% 17% 12%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025
Digital Units Penetration - Domestic Lab
%

Log in to view insights

Please log in to see hidden values.

Login
Digital Units Penetration - International Lab
%
Domestic Lab Metal-Free Revenue Share
%
Aligner Solutions Total Cases
Cases
Dental Network Size
Number (Dentists/Clinics)
Domestic Lab Units Sold
Units
Employee Strength
Count
International Lab Units Sold
Units
Pediatric (Kids-E-Dental) Units Sold
Units
Intraoral Scanners Deployed
Units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

8 Recently
Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
41.70% 41.70% 41.70% 41.70% 41.77%
34.24% 33.59% 32.39% 32.45% 31.20%
12.86% 14.30% 11.85% 10.82% 10.52%
11.19% 10.39% 14.05% 15.01% 16.50%
No. of Shareholders 29,48227,95737,90938,63538,161

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls